Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02118324 · ClinicalTrials.gov registry record · NA
Exergaming Intervention in ALL Patients
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02118324 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 35 participants.
The verdict
NCT02118324, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is a pilot feasibility study to collect preliminary data for a large-scale exergaming intervention in children undergoing maintenance therapy for Acute Lymphoblastic Leukemia (ALL). Patients, ages 5-17 years will be randomized to the intervention or non-intervention control group. The intervention will consist of 30 minute sessions of exergaming 3-5 times a week for 6 months, with weekly assessment of exercise level and phone calls by kinesiology graduate students for safety and compliance. Physical activity at baseline and at the end of study will be assessed using accelerometers. Outcome measures will include: anthropometrics, blood pressure, body composition, visceral fat, vascular function, fasting insulin, fasting glucose, LDL-cholesterol, HDL- cholesterol, triglycerides, functional mobility and endurance, and strength.
Interventions
- BEHAVIORAL Exergaming Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02118324
The ClinicalTrials.gov registry entry for NCT02118324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exergaming Program is the first listed.
NCT02118324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02118324 about?
NCT02118324 is a clinical study titled "Exergaming Intervention in ALL Patients". This is a pilot feasibility study to collect preliminary data for a large-scale exergaming intervention in children undergoing maintenance therapy for Acute Lymphoblastic Leukemia (ALL). Patients, ages 5-17 years will be randomized to the intervention or non-intervention control group. The intervent...
What is the current status of trial NCT02118324?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2014-03. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02118324?
The interventions under investigation include: Exergaming Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02118324?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.